80048166-2 - Therapeutic Switching in MS: Implementing New Guidelines in Clinical Practice - eCase Challenge

Thursday, January 31, 2019, 12:00 AM - Friday, January 31, 2020, 12:00 AM EST


Utilizing the Clinical Dialogue and eCase Challenge online platform, the programs will be created for the target audience to deliver this educational curriculum. Clinical Dialogue will address  2018 American Academy of Neurology (AAN) recommendations for use of DMTs in patients with MS: patient monitoring, when to switch therapies, and how to switch therapies, monitoring patients with MS to determine when a switch in therapy should be considered, and how to determine DMT to which patient should be switched. eCase Challenge will address components of monitoring per 2018 AAN guidelines, findings on follow-up at 12 months, factors to consider when deciding whether to switch therapy per AAN guidelines and factors to consider when selecting a DMT to which patient should be switched per AAN Guidelines.

Content for this activity can be found here

Policy on Speaker and Provider Disclosure
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Johns Hopkins Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Internet CME Policy
The Office of Continuing Medical Education (OCME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University School of Medicine OCME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.

Copyright
All rights reserved - The Johns Hopkins University School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Format and Method of Participation
Review this internet-based CME activity. To take the post-test, please click on the post-test button below the video window of the player which will take you to the Johns Hopkins University School of Medicine’s website. If you already have registered for other programs at this website, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. The information you enter here will be used to generate your CME certificate. Please complete all fields to ensure accurate registration. Complete the post-test and evaluation and attest to the amount of time spent in the activity. Upon receiving a score of 70% or above, print your CME certificate.

Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Faculty
Daniel M. Harrison, MD – Principal Investigator: EMD Serono, Genentech, Inc.; Advisory Board: Biogen Idec, EMD Serono, Genentech Inc., Genzyme Corporation; Royalty: UpToDate

Daniel Ontaneda, MD, MSc – Principal Investigator: Genentech, Inc., Genzyme Corporation, Novartis AG; Consulting Fee: Biogen Idec, Genentech Inc., Novartis AG

Shiv Saidha, MBBCh, MD, MRCPI – Principal Investigator: Biogen Idec, Genentech, Inc., MedDay Pharmaceuticals; Advisory Board: Biogen Idec, EMD Serono, Genzyme Corporation, Novartis AG; Ownership Interest: JuneBrain

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Off-Label Discussion
The following speakers have disclosed that their presentation will reference unlabeled/unapproved uses of drugs or products:
Daniel Ontaneda, MD, MSc: cladribine

Disclaimer
The opinions and recommendations expressed by faculty and other experts, whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANTS
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person’s health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: [email protected].

“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.”

For CME Questions, please contact the CME Office (410) 955-2959 or e-mail [email protected].

For CME Certificates, please call (410) 502-9634.
Johns Hopkins University School of Medicine
Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03) (Updated 4/09 and 3/14)

Privacy Statement/Internet Policy
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. Continuing Medical Education collects only the information necessary to provide you with the services that you request.

AMERICANS WITH DISABILITIES ACT
The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit https://hopkinscme.cloud-cme.com

Technical Requirements
PC

• Processor Speed: 1.4 GHz P4
• Memory: 2 GB RAM (20MB available)
• Operating Systems Supported: Windows 8 or greater
• Browsers Supported: Internet Explorer 9 or greater, Mozilla Firefox and Chrome
• Additional Requirements: Flash player 10.0 or greater, 1024 x 768 Resolution or higher with 32-bit color
• Connection Speed: 2 Mbps or better
• Adobe Acrobat 6.0 or greater

MAC

• Processor Speed: G4 processor or higher
• Memory: 2 GB RAM
• Operating Systems Supported: OSX 10.7 or greater
• Browsers Supported: Mozilla Firefox, Chrome and Safari 8 or greater
• Additional Requirements: Flash player 10.0 or greater
• 1024x768 Resolution or Higher with 32-bit color
• Connection Speed: 512 Kbps or better
• Adobe Acrobat Reader 6.0 or greater

In cooperation with Medical Logix, LLC.
© All rights reserved – The Johns Hopkins University School of Medicine.

1. Apply the 2018 American Academy of Neurology (AAN) guidelines on DMTs to monitor the efficacy, tolerability, and safety of therapy in patients with MS.
2. Implement recommendations from the 2018 AAN guidelines to determine when a switch in DMTs should be considered for patients with MS.
3. Integrate the 2018 AAN guidelines into the process of selecting therapy when switching DMTs in patients with MS.

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of PAs (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. PAs may receive a maximum of .75 AAPA Category 1 Credit for completing this program.